EMAIL THIS PAGE TO A FRIEND

[Rinsho ketsueki] The Japanese journal of clinical hematology

[Successful treatment with the combination of recombinant human soluble thrombomodulin and gabexate mesilate in three patients with obstetric disseminated intravascular coagulation].


PMID 21403426

Abstract

Recombinant human soluble thrombomodulin (rTM) is a new drug for the treatment of disseminated intravascular coagulation (DIC), although the effects on obstetric DIC have not yet been fully elucidated. We report herein three patients with obstetric DIC caused by placental abruption, hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome, and atonic bleeding, respectively. In all three cases, treatment with rTM proved successful, suggesting that rTM is an efficient method for treating obstetric DIC.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

G2417
Gabexate mesylate, analytical standard, for drug analysis
C16H23N3O4 · CH4O3S